Sea Mild Biotechnology , Ltd. Accounts Payable

Sea Mild Biotechnology , Ltd. (7516.TWO) currently reports a accounts payable of $64M as of June 2026. That compares with $47M in the prior-year period — up 38.4% year over year. Use the charts on this page to explore Sea Mild Biotechnology , Ltd.'s accounts payable history and peer comparisons.

Sea Mild Biotechnology , Ltd.'s accounts payable increased from $47M to $64M — a 38.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sea Mild Biotechnology , Ltd. reported $64M in accounts payable as of June 2026. That compares with $47M in the prior-year period — up 38.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sea Mild Biotechnology , Ltd., and consider following 7516.TWO for alerts when major investors trade the stock.